Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

19 juil. 2021 08h00 HE | Source: Aerovate Therapeutics, Inc.

Aerovate Therapeutics Appoints Allison Dorval To Its Board of Directors

BOSTON, July 19, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of...
02 juil. 2021 16h01 HE | Source: Aerovate Therapeutics, Inc.

Aerovate Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

BOSTON, July 02, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of...
29 juin 2021 22h59 HE | Source: Aerovate Therapeutics, Inc.

Aerovate Therapeutics Announces Pricing of Upsized Initial Public Offering

BOSTON, June 29, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of...
18 mai 2021 07h00 HE | Source: Aerovate Therapeutics, Inc.

Aerovate Therapeutics Appoints Timothy Noyes as Chief Executive Officer

BOSTON, May 18, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Aerovate), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of...